Combined reverse osmosis and UV/H 2 O 2 treatment of aqueous solutions of bisphenol A and 17α-ethinylestradiol: assessment of estrogenic activity

• Published in: Environmental technology Vol. 44; no. 20; pp. 3108 - 3120
• Main Authors: Moreira, Carolina G, de Souza, Larissa C, Castor Neto, Thayanne C, Gomes, Giselle, Bila, Daniele M, Fonseca, Fabiana V
• Format: Journal Article
• Language: English
• Published: England 06.09.2023
• Subjects: Bisphenol-A (BPA); UV/H2O2; reverse osmosis (RO); yeast estrogen screen (YES); 17α-ethinylestradiol (EE2)
• ISSN: 0959-3330; 1479-487X
• DOI: 10.1080/09593330.2022.2051608

Bisphenol-A (BPA) and 17α-ethinylestradiol (EE2) are considered endocrine disrupting compounds (EDC) and they may be harmful to the normal functioning of endocrine systems of humans and animals. Moreover, the presence of these compounds in superficial and groundwater may represent serious risks, even in low concentrations like ng·L . The objectives of this study were to remove BPA and EE2 from solutions containing a mixture of these compounds in ultrapure water at low concentrations through reverse osmosis (RO) membrane combined with a UV/H O process. Furthermore, to assess the estrogenic activity reduction after such treatments, recombinant yeast-estrogen screen (YES) assay was used. The removal efficiencies of target micropollutants increased with the increase of H O dosage. For RO permeate stream, they enhanced from 91% to 96% for EE2 and from 76% to 90% for BPA while, for the concentrate stream, from 70% to 81% for EE2 and 41% to 84% for BPA as the H O concentration were increased from 100 to 1000 µg·L . The OH radicals' generation was the dominant factor in the degradation of EDC during the UV/H O treatment since the photolysis itself was not enough to degrade BPA or EE2. The estrogenic activity reduction after UV/H O treatment was high, ranging from 92% to 98% for the permeate stream and from 50% to 93% for the concentrate stream. The EE2 was responsible for the whole observed estrogenic activity since BPA does not present estrogenicity, by YES assay, in the concentrations observed.